CD19 and neoplasm: Figure 6C shows that CAR19-iNK-like exerted superior anti-tumor activity against REH and Raji cells when compared with WT-iNK-like cells, while having a minimal effect on K562 cells, indicating that they were functionally competent with high specificity toward target tumor cells presenting CD19 antigen.